Figure 8 displays a forest plot for the network meta-analysis of studies reporting change from baseline in radiographic joint damage score. One comparison was used in this analysis. Study-level data used in this Figure are presented in Appendix C. This figure is described further in the KQ1 Results section “Non-TNF Biologic: MTX Plus Non-TNF With Either MTX or Non-TNF Biologic” as follows: “There were no significant differences in radiographic progression (SMD, −0.03; 95% CI, −0.17 to 0.11)”.

Figure 8Forest plot for network meta-analysis of change from baseline in radiographic joint damage score: MTX plus non-TNF versus non-TNF biologic

95% CI = 95% confidence interval; MTX = methotrexate; SMD = standardized mean difference (mean difference divided by standard deviation); TNF = tumor necrosis factor; vs. = versus.

From: Results

Cover of Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 211.
Donahue KE, Gartlehner G, Schulman ER, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.